Antibiotics have always been on the top priorities in medicine development. But nowadays, antibiotic-resistant bacterias are making the use of this solution very limited and quite frustrating. A [...]
Alsachim is glad to be attending CPHI 2019 in Frankfurt and will be showcasing its products in the Fine Chemicals exhibition at booth 80971NEP! CPhI Worldwide is the world's largest [...]
Alsachim has developed a new Tyrosine Kinase Inhibitors stable labeled standards, you can now get access to these standards to boost your research. Tyrosine Kinase inhibitors have always been [...]
5 Fluoro-uracil toxicity has been proven and a pre-treatment assessment is now mandatory. Alsachim has developed the standards essential for the analysis. Uracil [13C,15N2] [...]
A new and unique revelation has been uncovered by Alsachim. For the first time ever, the one of a kind stable labeled standard of Thiotepa, [13C6] Thiotepa, is available. This represents a big [...]
Alsachim has obtained ISO 13485 certification for its in vitro diagnostic kits business, demonstrating the company's ability to meet regulatory requirements and its commitment to the quality of [...]
Search on news
News > News
News archives
29.11.2019
![[13C6] Brigatinib, new Tyrosine Kinase Inhibitors available now](/modules/prestablog/views/img/grid-for-1-7/up-img/thumb_14.jpg?26f2a7c4917fd3bcb8982acb44147e5e)
![[13C6] Thiotepa: A new era for the anticancer research!](/modules/prestablog/views/img/grid-for-1-7/up-img/thumb_12.jpg?26f2a7c4917fd3bcb8982acb44147e5e)
13.06.2019
20.05.2019